astrazeneca glp 1 AstraZeneca's Bydureon gets a facelift, but can it stand out in a GLP-1 market that's only getting tougher? Astrazeneca divulges new GLP-1R agonists

Eli Lillys tirzepatide-based drugs, Mounjaro and Zepbound, have demonstrated superior efficacy in clinical trials, with Zepbound showing more significant weight loss compared to Wegovy

Bringing addiction treatment 'inside the house of medicine' In addition to food addiction, GLP-1s show promise for opioid, alcohol and nicotine addiction Early studies suggest that GLP-1s may be effective in treating opioid, alcohol and nicotine addiction

The team at Mind Matters Psychiatry & Weight Loss in Longwood, Florida, specializes in evidence-based medical weight-loss programs, including GLP-1 therapies such as semaglutide and tirzepatide.

the serendipitous discovery of exenatide by scientists fascinated with venom ( [22] ) ( [23] )), clinicians (adapting practice guidelines to incorporate these new therapies), patients (experiencing improved quality of life and weight loss), and public health experts (weighing the societal impact of widespread GLP-1 use)

Diabetol Metab Syndr 16 , 92 (2024)

Whilst GLP-1 medications are not currently licensed specifically for binge eating disorder in the UK, emerging research is exploring their potential therapeutic role